HALO:
Analysis & Opinions
-
December 26, 2012
Pfizer (PFE) recently entered into two deals. While one deal was signed with biopharma company Halozyme ...
-
December 21, 2012
The market is down this morning. The Nasdaq has decreased 2%; the S&P 500 has slipped 1.9%; and the Dow is down ...
-
December 21, 2012
On a bad day for the market, the Nasdaq has slipped 2%, the S&P 500 is trading down 1.9% and the Dow is down 1.4%. ...
-
November 14, 2012
ViroPharma Inc. (VPHM) presented promising data on Cinryze at the American College of Allergy, Asthma and ...
-
October 29, 2012
ViroPharma Inc.'s (VPHM) third quarter 2012 adjusted earnings (including stock based compensation) of 3 cents per ...
-
September 25, 2012
The US Food and Drug Administration (FDA) recently informed ViroPharma Incorporated (VPHM) that the company may ...
-
September 21, 2012
Currently, the Nasdaq has moved little, the S&P 500 is trading down 0.3% and the Dow has remained steady. The ...
-
August 10, 2012
ViroPharma Inc.'s (VPHM) second quarter 2012 adjusted earnings of 2 cents per share was well short of the Zacks ...
-
August 07, 2012
The US Food and Drug Administration (FDA) recently approved ViroPharma Incorporated's (VPHM) supplement to the ...
-
August 03, 2012
ViroPharma Incorporated (VPHM) recently announced that the US Food and Drug Administration (FDA) has advised the ...
-
December 03, 2010
Merck is making an exciting bet on a possible diabetes breakthrough.
-
October 21, 2010
Will Biodel's upcoming PDUFA date give investors a treat or just leave a sour taste?
